Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis andIn Vitro

Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non-Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption

(2014) M. Chan et al.   CANCER RESEARCH

Nicotinamide Phosphoribosyl Transferase/Pre-B Cell Colony-Enhancing Factor/Visfatin Is Required for Lymphocyte Development and Cellular Resistance to Genotoxic Stress

(2014) A. Rongvaux et al.   JOURNAL OF IMMUNOLOGY

Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort

(2014) Ondřej Sglunda et al.   PLoS One

Metabolomics Analysis of Metabolic Effects of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibition on Human Cancer Cells

(2014) Vladimir Tolstikov et al.   PLoS One

Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis

(2013) Jessy Présumey et al.   ANNALS OF THE RHEUMATIC DISEASES

Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience

(2013) By Fabrizio Montecucco et al.   CURRENT DRUG TARGETS

Decreased Expression of Nicotinamide Phosphoribosyltransferase in Patients with Juvenile Idiopathic Arthritis Receiving Methotrexate

(2013) E. J. FOX et al.   JOURNAL OF RHEUMATOLOGY

Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients

(2013) Sahar Hossam El-Hini et al.   RHEUMATOLOGY INTERNATIONAL

Optimization of Pediatric Rheumatology Therapeutics

(2012) M L Becker   CLINICAL PHARMACOLOGY & THERAPEUTICS

PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis?

(2012) Mari Nowell et al.   Future Medicinal Chemistry

Potential Role of Poly(ADP-Ribose) Polymerase (PARP) Activation in Methotrexate-Induced Nephrotoxicity and Tubular Apoptosis

(2012) Selvinaz Dalaklioglu et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

Visfatin/Pre-B-cell Colony-enhancing Factor (PBEF), a Proinflammatory and Cell Motility-changing Factor in Rheumatoid Arthritis

(2012) Florian M. P. Meier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Suppression of leukocyte infiltration and cartilage degradation by selective inhibition of pre-B cell colony-enhancing factor/visfatin/nicotinamide phosphoribosyltransferase: Apo866-mediated therapy in human fibroblasts and murine collagen-induced arthrit

(2011) Laura Evans et al.   ARTHRITIS AND RHEUMATISM

Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis

(2011) Inge R. Klein-Wieringa et al.   ARTHRITIS AND RHEUMATISM

The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy

(2011) Ladislav Šenolt et al.   CYTOKINE

Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans

(2011) D. Friebe et al.   DIABETOLOGIA

Adiponectin, Resistin und Visfatin in Serum und Gelenkflüssigkeit bei Patienten mit rheumatoider Arthritis

(2011) E.A.M. Alkady et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Proteomic analysis by two-dimensional electrophoresis to identify the normal human chondrocyte proteome stimulated by tumor necrosis factor α and interleukin-1β

(2010) Berta Cillero-Pastor et al.   ARTHRITIS AND RHEUMATISM

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis

(2009) Young Hee Rho et al.   ARTHRITIS AND RHEUMATISM

Extracellular Nampt Promotes Macrophage Survival via a Nonenzymatic Interleukin-6/STAT3 Signaling Mechanism

(2008) Yankun Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD

(2008) Nathalie Busso et al.   PLoS One